Cargando…
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
Pharmacogenomics can identify polymorphisms in genes involved in drug pharmacokinetics and pharmacodynamics determining differences in efficacy and safety and causing inter-individual variability in drug response. Therefore, pharmacogenomics can help clinicians in optimizing therapy based on patient...
Autores principales: | Iannaccone, Teresa, Sellitto, Carmine, Manzo, Valentina, Colucci, Francesca, Giudice, Valentina, Stefanelli, Berenice, Iuliano, Antonio, Corrivetti, Giulio, Filippelli, Amelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001195/ https://www.ncbi.nlm.nih.gov/pubmed/33804537 http://dx.doi.org/10.3390/ph14030204 |
Ejemplares similares
-
Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
por: Conti, Valeria, et al.
Publicado: (2020) -
Opposite Response to Vitamin K Antagonists: A Report of Two Cases and Systematic Review of Literature
por: Conti, Valeria, et al.
Publicado: (2022) -
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19
por: Sabbatino, Francesco, et al.
Publicado: (2023) -
Identification of Drug Interaction Adverse Events in Patients With COVID-19: A Systematic Review
por: Conti, Valeria, et al.
Publicado: (2022) -
Antioxidant Supplementation Hinders the Role of Exercise Training as a Natural Activator of SIRT1
por: Sellitto, Carmine, et al.
Publicado: (2022)